Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
78.66 USD | -1.13% |
|
-1.70% | +27.30% |
Jun. 27 | Lantheus Holdings Acquires Global Rights to Life Molecular Imaging's RM2 | MT |
Jun. 26 | B. Riley Raises Price Target on Lantheus Holdings to $105 From $99, Maintains Buy Rating | MT |
Evolution of the average Target Price on Lantheus Holdings, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Lantheus Holdings, Inc.
Truist Securities | |
B. Riley | |
William Blair & Co. | |
TD Cowen | |
Brookline Capital Markets | |
Mizuho Securities | |
JMP Securities | |
JonesTrading Institutional Services | |
SVB Securities LLC | |
SVB Leerink | |
Credit Suisse |
EPS Revisions
- Stock Market
- Equities
- LNTH Stock
- Consensus Lantheus Holdings, Inc.